{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T22:42:37Z","timestamp":1782168157884,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00381-022-05531-6","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T18:05:56Z","timestamp":1650909956000},"page":"2205-2209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Multiple craniospinal tumors in a pediatric patient with neurofibromatosis type 2: a case report"],"prefix":"10.1007","volume":"38","author":[{"given":"Bo-Seob","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8685-8520","authenticated-orcid":false,"given":"Tae-Young","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Youl","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Jo","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seul-Kee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"issue":"1","key":"5531_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1212\/WNL.54.1.71","volume":"54","author":"J Antinheimo","year":"2000","unstructured":"Antinheimo J, Sankila R, Carpen O, Pukkala E, Sainio M, Jaaskelainen J (2000) Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 54(1):71\u201376","journal-title":"Neurology"},{"issue":"1","key":"5531_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/00129492-200501000-00016","volume":"26","author":"DG Evans","year":"2005","unstructured":"Evans DG, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R (2005) Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otol Neurotol 26(1):93\u201397","journal-title":"Otol Neurotol"},{"issue":"5","key":"5531_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/onc.2015.125","volume":"35","author":"AM Petrilli","year":"2016","unstructured":"Petrilli AM, Fernandez-Valle C (2016) Role of merlin\/NF2 inactivation in tumor biology. Oncogene 35(5):537\u2013548","journal-title":"Oncogene"},{"issue":"6080","key":"5531_CR4","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/322644a0","volume":"322","author":"BR Seizinger","year":"1986","unstructured":"Seizinger BR, Martuza RL, Gusella JF (1986) Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma. Nature 322(6080):644\u2013647","journal-title":"Nature"},{"issue":"5","key":"5531_CR5","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/0092-8674(93)90406-G","volume":"72","author":"JA Trofatter","year":"1993","unstructured":"Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72(5):791\u2013800","journal-title":"Cell"},{"issue":"9679","key":"5531_CR6","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/S0140-6736(09)60259-2","volume":"373","author":"AR Asthagiri","year":"2009","unstructured":"Asthagiri AR, Parry DM, Butman JA, Kim HJ, Tsilou ET, Zhuang Z (2009) Neurofibromatosis type 2. Lancet 373(9679):1974\u20131986","journal-title":"Lancet"},{"issue":"9","key":"5531_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/GIM.0b013e3181ac9a27","volume":"11","author":"DG Evans","year":"2009","unstructured":"Evans DG (2009) Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II]. Genet Med 11(9):599\u2013610","journal-title":"Genet Med"},{"issue":"1","key":"5531_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3171\/2012.3.JNS111649","volume":"117","author":"MS Dirks","year":"2012","unstructured":"Dirks MS, Butman JA, Kim HJ, Wu T, Morgan K, Tran AP (2012) Long-term natural history of neurofibromatosis type 2-associated intracranial tumors. J Neurosurg 117(1):109\u2013117","journal-title":"J Neurosurg"},{"issue":"1","key":"5531_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00381-010-1238-3","volume":"27","author":"T Stachowicz-Stencel","year":"2011","unstructured":"Stachowicz-Stencel T, Synakiewicz A, Bien E, Adamkiewicz-Drozynska E, Wybieralska-Dubaniewicz M, Balcerska A (2011) Multiple primary cranio-spinal tumours in a 13-year-old female with neurofibromatosis type 2 management strategy. Childs Nerv Syst 27(1):175\u2013178","journal-title":"Childs Nerv Syst"},{"issue":"5","key":"5531_CR10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.neuchi.2014.11.012","volume":"64","author":"R Aboukais","year":"2018","unstructured":"Aboukais R, Bonne NX, Baroncini M, Zairi F, Schapira S, Vincent C (2018) Management of multiple tumors in neurofibromatosis type 2 patients. Neurochirurgie 64(5):364\u2013369","journal-title":"Neurochirurgie"},{"issue":"2","key":"5531_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1399-0004.2009.01315.x","volume":"77","author":"SK Selvanathan","year":"2010","unstructured":"Selvanathan SK, Shenton A, Ferner R, Wallace AJ, Huson SM, Ramsden RT (2010) Further genotype-phenotype correlations in neurofibromatosis 2. Clin Genet 77(2):163\u2013170","journal-title":"Clin Genet"},{"issue":"10","key":"5531_CR12","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/jnen\/60.10.994","volume":"60","author":"A Perry","year":"2001","unstructured":"Perry A, Giannini C, Raghavan R, Scheithauer BW, Banerjee R, Margraf L (2001) Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases. J Neuropathol Exp Neurol 60(10):994\u20131003","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"5531_CR13","first-page":"274","volume":"49","author":"DE Brackmann","year":"2001","unstructured":"Brackmann DE, Fayad JN, Slattery WH III, Friedman RA, Day JD, Hitselberger WE (2001) Early proactive management of vestibular schwannomas in neurofibromatosis type 2. Neurosurgery 49(2):274\u2013283","journal-title":"Neurosurgery"},{"key":"5531_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000156907","volume":"21","author":"J Rowe","year":"2008","unstructured":"Rowe J, Radatz M, Kemeny A (2008) Radiosurgery for type II neurofibromatosis. Prog Neurol Surg 21:176\u2013182","journal-title":"Prog Neurol Surg"},{"issue":"1","key":"5531_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ijrobp.2008.03.073","volume":"73","author":"S Wentworth","year":"2009","unstructured":"Wentworth S, Pinn M, Bourland JD, Deguzman AF, Ekstrand K, Ellis TL (2009) Clinical experience with radiation therapy in the management of neurofibromatosis-associated central nervous system tumors. Int J Radiat Oncol Biol Phys 73(1):208\u2013213","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"21","key":"5531_CR16","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1212\/WNL.0000000000000997","volume":"83","author":"J Blakeley","year":"2014","unstructured":"Blakeley J, Schreck KC, Evans DG, Korf BR, Zagzag D, Karajannis MA (2014) Clinical response to bevacizumab in schwannomatosis. Neurology 83(21):1986\u20131987","journal-title":"Neurology"},{"issue":"2","key":"5531_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11060-019-03234-8","volume":"144","author":"VM Lu","year":"2019","unstructured":"Lu VM, Ravindran K, Graffeo CS, Perry A, Van Gompel JJ, Daniels DJ (2019) Efficacy and safety of bevacizumab for vestibular schwannoma in neurofibromatosis type 2: a systematic review and meta-analysis of treatment outcomes. J Neurooncol 144(2):239\u2013248","journal-title":"J Neurooncol"},{"issue":"4","key":"5531_CR18","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1056\/NEJMoa0902579","volume":"361","author":"SR Plotkin","year":"2009","unstructured":"Plotkin SR, Stemmer-Rachamimov AO, Barker FG II, Halpin C, Padera TP, Tyrrell A (2009) Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med 361(4):358\u2013367","journal-title":"N Engl J Med"},{"issue":"35","key":"5531_CR19","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1200\/JCO.19.01367","volume":"37","author":"SR Plotkin","year":"2019","unstructured":"Plotkin SR, Duda DG, Muzikansky A, Allen J, Blakeley J, Rosser T (2019) Multicenter, prospective, phase II and biomarker study of high-dose bevacizumab as induction therapy in patients with neurofibromatosis type and progressive vestibular schwannoma. J Clin Oncol 37(35):3446\u20133454","journal-title":"J Clin Oncol"},{"issue":"1","key":"5531_CR20","doi-asserted-by":"publisher","first-page":"5758","DOI":"10.1038\/s41467-019-13640-1","volume":"10","author":"R Tamura","year":"2019","unstructured":"Tamura R, Fujioka M, Morimoto Y, Ohara K, Kosugi K, Oishi Y (2019) A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2. Nat Commun 10(1):5758","journal-title":"Nat Commun"},{"issue":"4","key":"5531_CR21","doi-asserted-by":"publisher","first-page":"e35711","DOI":"10.1371\/journal.pone.0035711","volume":"7","author":"SR Plotkin","year":"2012","unstructured":"Plotkin SR, Bredella MA, Cai W, Kassarjian A, Harris GJ, Esparza S (2012) Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis. PLoS ONE 7(4):e35711","journal-title":"PLoS ONE"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-022-05531-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-022-05531-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-022-05531-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T11:06:11Z","timestamp":1667041571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-022-05531-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["5531"],"URL":"https:\/\/doi.org\/10.1007\/s00381-022-05531-6","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]},"assertion":[{"value":"27 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complies with the World Medical Association Declaration of Helsinki and this retrospective study was approved by the Institutional Review Board of Chonnam National University Hwasun Hospital. Written informed consent was obtained from the patient\u2019s parents for publication of this case report and any accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have no conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}